HIV prevention study for pregnant women
This study looks at how well a daily pill called PrEP can prevent HIV in pregnant women and their babies. It aims to make sure these women get the support they need to stay healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You do not have HIV.
- If you are pregnant, you are at least 18 weeks along.
- You are eligible for PrEP according to South African health guidelines.
- You can give your informed consent to join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help women at risk for HIV stay healthy while planning or having children. It provides prevention tools and support to reduce the chance of getting HIV.
This study aims to expand access to PrEP (a daily pill that prevents HIV) for pregnant and postpartum women visiting maternal and child health clinics in Kenya. It also includes health care workers who provide PrEP services.
This study offers HIV self-testing kits to the partners of pregnant women and new mothers who are HIV-negative. It aims to make testing easier and more accessible for partners whose HIV status is unknown.
This study is for people who are HIV-negative and want to take PrEP (a daily pill that prevents HIV). It will help researchers learn more about how to best support people taking PrEP in real-world settings.
This study tests ways to help Black cisgender women take PrEP, a daily pill that prevents HIV infection. It focuses on making PrEP work for you.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.